文献速递炎症性肠病胃肠动力与功能性疾病

低FODMAP饮食对静止期IBD患者症状、肠道菌群及炎症标志物的随机试验

Effects of Low FODMAP Diet on Symptoms, Fecal Microbiome, and Markers of Inflammation in Patients With Quiescent Inflammatory Bowel Disease in a Randomized Trial.
PubMed 文献 · Gastroenterology · 2019-10-02

该单盲随机对照试验纳入52例静止期IBD伴持续肠道症状患者,分别接受低FODMAP饮食(n=27)或对照饮食(n=25)4周。低FODMAP组粪便中青春双歧杆菌、长双歧杆菌和普拉梭菌丰度显著降低,菌群多样性和炎症标志物无显著组间差异。

要点

  • 低FODMAP饮食4周可改善静止期IBD患者的症状缓解率和生活质量。
  • 该饮食降低粪便中双歧杆菌和普拉梭菌丰度,但不影响菌群多样性和炎症标志物。
  • IBS严重度评分变化未达统计学显著差异。

核心结论

  • 4周低FODMAP饮食对静止期IBD患者的持续肠道症状安全有效,但会降低部分免疫调节相关菌群的粪便丰度。

研究设计与样本

  • 单盲随机对照试验,纳入52例静止期克罗恩病或溃疡性结肠炎伴持续肠道症状患者,随机分为低FODMAP饮食组(n=27)和对照饮食组(n=25),干预4周。

主要发现

  • 研究结束时低FODMAP组粪便中青春双歧杆菌、长双歧杆菌和普拉梭菌丰度显著低于对照组。
  • 菌群多样性和循环炎症标志物在两组间无显著差异。

临床怎么用

  • 对静止期IBD伴持续肠道症状的患者,可考虑短期(4周)低FODMAP饮食以改善症状和生活质量。
  • 实施低FODMAP饮食时需关注其对有益菌群(如双歧杆菌和普拉梭菌)的潜在降低作用。

局限性

  • 样本量较小(共52例),研究周期短(4周)。
  • 单盲设计可能引入偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: There is limited evidence that a diet low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAPs) reduces gut symptoms in quiescent inflammatory bowel disease (IBD). We performed a randomized, controlled trial to investigate the effects of a low FODMAP diet on persistent gut symptoms, the intestinal microbiome, and circulating markers of inflammation in patients with quiescent IBD. METHODS: We performed a single-blind trial of 52 patients with quiescent Crohn's disease or ulcerative colitis and persistent gut symptoms at 2 large gastroenterology clinics in the United Kingdom. Patients were randomly assigned to groups that followed a diet low in FODMAPs (n = 27) or a control diet (n = 25), with dietary advice, for 4 weeks. Gut symptoms and health-related quality of life were measured using validated questionnaires. Stool and blood samples were collected at baseline and end of trial. We assessed fecal microbiome composition and function using shotgun metagenomic sequencing and phenotypes of T cells in blood using flow cytometry. RESULTS: A higher proportion of patients reported adequate relief of gut symptoms following the low FODMAP diet (14/27, 52%) than the control diet (4/25, 16%, P=.007). Patients had a greater reduction in irritable bowel syndrome severity scores following the low FODMAP diet (mean reduction of 67; standard error, 78) than the control diet (mean reduction of 34; standard error, 50), although this difference was not statistically significant (P = .075). Following the low FODMAP diet, patients had higher health-related quality of life scores (81.9 ± 1.2) than patients on the control diet (78.3 ± 1.2, P = .042). A targeted analysis revealed that in stool samples collected at the end of the study period, patients on the low FODMAP diet had significantly lower abundance of Bifidobacterium adolescentis, Bifidobacterium longum, and Faecalibacterium prausnitzii than patients on control diet. However, microbiome diversity and markers of inflammation did not differ significantly between groups. CONCLUSIONS: In a trial of the low FODMAP diet vs a control diet in patients with quiescent IBD, we found no significant difference after 4 weeks in change in irritable bowel syndrome severity scores, but significant improvements in specific symptom scores and numbers reporting adequate symptom relief. The low FODMAP diet reduced fecal abundance of microbes believed to regulate the immune response, compared with the control diet, but had no significant effect on markers of inflammation. We conclude that a 4-week diet low in FODMAPs is safe and effective for managing persistent gut symptoms in patients with quiescent IBD. www.isrctn.com no.: ISRCTN17061468.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Cox SR, Lindsay JO, Fromentin S, et al. Effects of Low FODMAP Diet on Symptoms, Fecal Microbiome, and Markers of Inflammation in Patients With Quiescent Inflammatory Bowel Disease in a Randomized Trial. Gastroenterology. 2019. PMID: 31586453. doi:10.1053/j.gastro.2019.09.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。